Importance of Long-Acting Injectable Antipsychotic Preparation, Administration, and Injection Site Tolerability: A Focus on Paliperidone Palmitate Once-Every-6-Months Formulation

<div>Mean visual analog scale scores for injection site pain by PP3M and PP6M doses. <i>Note</i>. PP3M, paliperidone palmitate once-every-3-months; PP6M, paliperidone palmitate once-every-6-months; VAS, visual analog scale. The VAS scale ranged from 0 (no pain at all) to 100 (unbearably painful). <sup>a</sup>VAS assessed within 30 minutes of injection. <sup>b</sup>For PP6M doses, placebo injections were given at months 3 and 9 to maintain double-blinding. <sup>c</sup>VAS residual. <sup>d</sup>VAS residual/LOCF.</div>

Perspectives in Psychiatric Care

fig5

Figure 5

Figure 5: Importance of Long-Acting Injectable Antipsychotic Preparation, Administration, and Injection Site Tolerability: A Focus on Paliperidone Palmitate Once-Every-6-Months Formulation 

Figure 5 | Importance of Long-Acting Injectable Antipsychotic Preparation, Administration, and Injection Site Tolerability: A Focus on Paliperidone Palmitate Once-Every-6-Months Formulation 